Myopotential oversensing in implantable defibrillators causing inhibition of pacing and inappropriate therapies is well described. Current literature is dominated by reports of diaphragmatic muscle as the source of such far-field oversensing. Those reporting pectoral muscle sources were invariably due to unipolar sensing circuits, incorrect DF-1 connections or inappropriate programming. We report an interesting case of pectoral muscle myopotential oversensing causing inhibition of bradycardia pacing leading to presyncope and syncope.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2572022PMC

Publication Analysis

Top Keywords

myopotential oversensing
8
causing inhibition
8
pectoral muscle
8
fortuitous syncope
4
syncope pitfalls
4
pitfalls integrated
4
integrated bipolar
4
bipolar defibrillator
4
defibrillator leads
4
leads myopotential
4

Similar Publications

Article Synopsis
  • The study aims to evaluate the performance and safety of subcutaneous-implantable cardioverter defibrillator (S-ICD) technology in athletes compared to nonathletes, focusing on device-related complications and shock occurrences.
  • Athletes made up 10.2% of the 1493 patients studied and showed higher incidences of certain heart conditions, with a tendency to experience appropriate shocks more frequently during exercise, although this was not statistically significant after adjusting for other factors.
  • Overall, S-ICDs appear to be a safe option for athletes, as there was no significant difference in overall complications or inappropriate shocks between the two groups, though athletes had a higher risk of myopotential oversensing and lead infections shortly after implant.
View Article and Find Full Text PDF

Background: The extravascular (EV) implantable cardioverter-defibrillator (ICD) includes features to address sensing and arrhythmia detection challenges presented by its substernal lead location.

Objectives: In this study, the authors sought to evaluate sensing and detection performance in 299 patients discharged with an EV-ICD in the global pivotal study.

Methods: We reviewed and adjudicated all induced ventricular fibrillation (VF) episodes and spontaneous device-stored episodes that satisfied rate and duration criteria in a programmed ventricular tachycardia (VT)/VF therapy zone.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the long-term outcomes of using a third-generation subcutaneous implantable cardioverter defibrillator (S-ICD) combined with the intermuscular two-incision technique in patients with arrhythmogenic cardiomyopathy (ACM).
  • Out of 23 patients followed for an average of 45.5 months, 17.4% experienced at least one inappropriate shock, primarily due to muscle activity during exertion, with no cases caused by T-wave oversensing.
  • The findings suggest that while the S-ICD implantation is generally safe with low complication rates, the risk of inappropriate shocks from myopotential during physical activity should be acknowledged.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!